Superficial punctate keratitis Thygeson

Nesbum AB, Lowe GH, Lapoff bjj, et al. Effect of topical trifluri-dine on Thygeson s superficial punctate keratitis. Ophthalmology 1984 91(10) 1188-1192. 

Topical CsA (2%) is a beneficial therapy for symptomatic treatment ofThygeson s superficial punctate keratitis. Topical corticosteroids are generally the first line of treatment. Secondary therapy includes extended-wear contact lenses and CsA. CsA, however, has been shown to be beneficial when used as the primary treatment. In one study long-term use of 2% topical CsA in olive oil (four times a day for 3 months followed by twice daily treatment for 1 month) was evaluated in eight Thygeson s ... 

Nagra PK, Rapuano CJ, Cohen EJ, Laibson PR.Thygeson s superficial punctate keratitis ten years experience. Ophthalmology 2004 111 34-37. 

Eite SW, Chodosh J. Photorefractive keratectomy for myopia in the setting of Thygeson s superficial punctate keratitis. Cornea 2001 20 425-426. [Comment in Cornea 2001 20 904 Cornea 2002 21 736-737 author reply 737.]... 

Netto MV, ChaUta MR, Krueger RR.Thygeson s superficial punctate keratitis recurrence after laser in situ keratomileusis. AmJ Ophthalmol 2004 138 507-508. 

Reinhard T, Roggendorf M, Eengler I, et al. PCR for varicella zoster virus genome negative in comeal epithelial cells of patients with Thygeson s superficial punctate keratitis. Eye 2004 18 304-305. 

---